Problematic issues related to screening for diabetic retinopathy
Authors:
P. Skalická; B. Kalvodová
Authors‘ workplace:
Oční klinika 1. lékařské fakulty UK a VFN Praha, přednostka doc. MUDr. Bohdana Kalvodová, CSc.
Published in:
Vnitř Lék 2013; 59(3): 218-223
Category:
Case Reports
Overview
The aim of this paper is to highlight the importance of screening for diabetic retinopathy and the education of diabetic patients. The key prerequisite of an effective screening is close collaboration between health care professionals. Successful screening detects DR at early stages and helps to prevent severe visual loss. Two cases of proliferative DR exhibiting the most serious complications (vitreous haemorrhage, traction retinal detachment and combined traction and rhegmatogenous retinal detachment, neovascular glaucoma) are reported. The first comorbid patient lost her vision despite the adequate treatment. The second patient was successfully managed with pars plana vitrectomy with final visual acuity better to the preoperative value.
Key words:
diabetic retinopathy – screening – indirect biomicroscopy
Sources
1. Kalvodová B. Screening diabetické retinopatie v ČR – guideline. Čes slov Oftal 2002; 58 : 3–10.
2. Sosna T. et al. Diabetická retinopatie – rizikové faktory, prevence a terapie. Čes slov Oftal 2010; 66 : 195–203.
3. Kalvodová B et al. Diagnostika a léčba diabetické retinopatie a jejích komplikací. DMEV Diabetologie 2002; 5 : 214–218.
4. Standardy pro diagnostiku a léčbu diabetické retinopatie a jejích komplikací. DMEV Diabetologie 2004; 7 : 22–25.
5. Ústav zdravotnických informací a statistiky ČR. Péče o nemocné s cukrovkou 2011 : 8.
6. Zhang X et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010; 304 : 649–656.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2013 Issue 3
-
All articles in this issue
- What has the largest study in the history of diabetology brought us?
- Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic – BIBY-I study (observations lasting 3 to 12 months)
- Patophysiology of diabetic retinopathy
- Risk factors for diabetic retinopathy
- Present state of diagnostic and screening of the diabetic retinopathy and diabetic macular oedema
- The benefit of pars plana vitrectomy for the resolution of complications of proliferative diabetic retinopathy
- Treatment of diabetic macular oedema
- Diabetic nephropathy/diabetic kidney disease
- Incretin therapy and diabetic retinopathy
- Present and future of insulin treatment
- Diabetic retinopathy in the Czech National Diabetes Programme 2012–2022
- Problematic issues related to screening for diabetic retinopathy
- Progression of diabetic retinopathy in pregnancy
- Diabetic macular oedema in the third trimester of pregnancy
- Treatment of diabetic macular oedema in a type 1 diabetes patient – mistakes in interdisciplinary collaboration
- Internal Medicine
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Diabetic nephropathy/diabetic kidney disease
- Treatment of diabetic macular oedema
- Progression of diabetic retinopathy in pregnancy
- Patophysiology of diabetic retinopathy